Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

64.44 USD -0.02 (-0.03%)
Official Closing Price Updated: 4:10 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,844,222
Open 64.70
Bid (Size) 64.35 (1)
Ask (Size) 64.43 (2)
Prev. Close 64.46
Today's Range 64.19 - 65.39
52wk Range 54.07 - 67.16
Shares Outstanding 2,232,843,755
Dividend Yield 3.04%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative
DarwinHealth, a New York City-based biotechnology company, today announced a scientific research collaboration with Bristol-Myers Squibb Company (NYSE: BMY). The research collaboration, the Novel... 
From PR Newswire
Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert

Performance

YTD
+4.99%
+4.99%
1 Month
+3.97%
+3.97%
3 Month
+4.68%
+4.68%
6 Month
+1.08%
+1.08%
1 Year
+5.41%
+5.41%

More News

Read More
Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies
From PR Newswire
Bristol Myers Squibb to Take Part in the 2021 Bank of America Securities Health Care Conference
From Business Wire News Releases
Bristol Myers Squibb Presents New Clinical and Real-World Data on Mavacamten and Obstructive Hypertrophic Cardiomyopathy at Upcoming American College of Cardiology’s 70th Annual Scientific Session
From Business Wire News Releases
Interesting BMY Put And Call Options For June 25th
Tags Stocks
From Market News Video
Analysts Predict 10% Gains Ahead For The Holdings of XLV
Tags ETFs
From ETF Channel
What Really Mattered With Editas Medicine's Q1 Update
Tags Market News BMY EDIT
From Motley Fool
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab) as Adjuvant Treatment for Patients with Muscle-Invasive Urothelial Carcinoma
From Business Wire News Releases
Market Briefing For Wednesday, May 5
Tags Technology Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
2 Top Stocks to Buy and Hold for 10 Years
Tags ABT BMY Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.